MelanocortinPT-141
10 mg · Lyophilized Powder
Cyclic peptide for melanocortin receptor pathway research.
Batch COA available by email on request
Published areas of interest.
This page summarises published research areas for general information. It does not establish safety, efficacy, or suitability for any use.
PT-141, or bremelanotide, is a synthetic cyclic peptide studied as a melanocortin-receptor agonist. Research includes controlled human clinical trials using specific pharmaceutical formulations.
Areas of research interest
Current evidence
Two sponsor-funded Phase 3 trials in premenopausal women reported group-level differences in self-reported outcomes. Nausea, flushing and headache were reported more often in active-study groups. Earlier research used different formulations and populations.
Important limitations
The pivotal studies enrolled a narrow population, relied on participant-reported outcomes and had limited blinded follow-up. Findings cannot be generalised to other formulations, populations or a catalogue item.
Documentation for this material.
Janoshik Certificate of Analysis available by email. Contact us with the product name and batch number.
Understand our testingFor research use only.
Not for human or animal consumption. Not an approved therapeutic good. The TGA identifies PT-141 as an unapproved therapeutic good in Australia.
How to order PT-141
Pay by bank transfer to Sempra Labs Pty Ltd, BSB 923100, Account 43679047, using your full name as the reference, plus $11 flat-rate shipping, then WhatsApp your remittance and order to 0428 717 379.